This content is machine translated Advanced NET of the midgut Radiopeptide therapy successful in disease progression Patients with advanced, progressive somatostatin receptor-positive neuroendocrine tumors (NET) of the midgut may benefit from so-called peptide-mediated radioreceptor therapy (PRRT), according to a publication in the New England Journal of…
View Post 3 min This content is machine translated Tumor Treating Fields (TTF) What’s the story with the new process? At the 21st meeting of the Society For Neuro-Oncology, presentations included a phase III trial of Tumor Treating Fields (TTF) treatment in newly diagnosed glioblastoma. From ESMO ASIA come results…
View Post 5 min This content is machine translated ESMO in Copenhagen and Singapore Immunotherapy puts lung cancer experts in turmoil Pembrolizumab returned to the international stage of lung cancer therapy with a thunderclap during the presentation of the KEYNOTE 024 trial at the 2016 ESMO Congress in Copenhagen. Lectures on…
View Post 8 min This content is machine translated Endometrial Cancer Practical basics and modern management The incidence of endometrial cancer is increasing. In postmenopausal women, it usually becomes noticeable early on with vaginal bleeding. More than 70% of patients are in FIGO stage I at…
View Post 5 min This content is machine translated ASH 2016 in San Diego Multiple Myeloma Review As every year, the ASH Congress took place in the busy pre-Christmas season. This time, experts from hematology and oncology met in San Diego. Multiple myeloma was again an important…
View Post 6 min This content is machine translated Chronic myeloid leukemia State of the Art – where are we at CML in 2017? CML patients have a normal life expectancy when treated with Abl-specific kinase inhibitors (TKIs) in chronic phase. Imatinib, dasatinib and nilotinib are approved in the first-line treatment of CML. In…
View Post 7 min This content is machine translated Indispensable for dense breast tissue Ultrasound diagnostics in breast carcinoma A number of studies have shown that ultrasound can detect carcinomas in addition to mammography, particularly in the dense breast. In the early detection of cancer in asymptomatic women, breast…
View Post 8 min This content is machine translated Radiotherapy Challenges and opportunities in elderly patients Despite the known demographic trends, we currently know too little with regard to old or even very old patients whether and how we can adapt and individualize radiotherapy (RT), especially…
View Post 7 min This content is machine translated Side effect profile of new oncological therapies Skin toxicity and alopecia Oncological therapies are undergoing rapid development, resulting in the availability of a large number of new substances that need to be characterized not only in terms of their potential uses…
View Post 5 min This content is machine translated DGHO Congress, Leipzig New treatment options for renal cell carcinoma and multiple myeloma Guidelines are intended to help introduce uniform standards with recommendations based on evidence-based data for diagnostics, therapy and follow-up care. At the annual meeting of the German, Austrian, and Swiss…
View Post 2 min This content is machine translated CDK4/6 inhibitors New class of drugs for breast cancer Adding the CDK4/6 inhibitor ribociclib to letrozole improved progression-free survival in postmenopausal women with hormone receptor-positive advanced breast cancer, researchers reported at the ESMO 2016 Congress in Copenhagen.
